A detailed history of Advisory Alpha, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Advisory Alpha, LLC holds 3,843 shares of MRK stock, worth $376,806. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,843
Previous 3,928 2.16%
Holding current value
$376,806
Previous $486,000 10.29%
% of portfolio
0.02%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$111.15 - $128.97 $9,447 - $10,962
-85 Reduced 2.16%
3,843 $436,000
Q2 2024

Aug 21, 2024

SELL
$123.8 - $132.96 $29,712 - $31,910
-240 Reduced 5.76%
3,928 $486,000
Q1 2024

May 06, 2024

SELL
$113.24 - $131.95 $86,515 - $100,809
-764 Reduced 15.49%
4,168 $549,000
Q4 2023

Jan 23, 2024

BUY
$100.18 - $109.02 $206,070 - $224,254
2,057 Added 71.55%
4,932 $537,000
Q3 2023

Oct 18, 2023

BUY
$102.95 - $114.33 $23,472 - $26,067
228 Added 8.61%
2,875 $295,000
Q2 2023

Jul 25, 2023

BUY
$108.61 - $118.38 $287,490 - $313,351
2,647 New
2,647 $305,000
Q4 2020

Feb 16, 2021

SELL
$71.77 - $79.65 $116,554 - $129,351
-1,624 Closed
0 $0
Q3 2020

Nov 06, 2020

BUY
$73.18 - $82.95 $118,844 - $134,710
1,624 New
1,624 $1.52 Million
Q2 2020

Aug 14, 2020

SELL
$70.42 - $80.13 $80,278 - $91,348
-1,140 Closed
0 $0
Q1 2020

Apr 29, 2020

BUY
$63.36 - $87.82 $6,969 - $9,660
110 Added 10.68%
1,140 $92.2 Million
Q4 2019

Feb 14, 2020

SELL
$77.58 - $87.54 $1,706 - $1,925
-22 Reduced 2.09%
1,030 $92.2 Million
Q3 2019

Nov 13, 2019

BUY
$76.08 - $82.93 $80,036 - $87,242
1,052 New
1,052 $84,000
Q2 2019

Aug 16, 2019

SELL
$69.84 - $81.59 $59,364 - $69,351
-850 Closed
0 $0
Q1 2019

May 13, 2019

BUY
$69.58 - $79.36 $59,143 - $67,456
850 New
850 $0

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Advisory Alpha, LLC Portfolio

Follow Advisory Alpha, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Alpha, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Alpha, LLC with notifications on news.